Grade and stage distribution according to the time of onset of acute GVHD
| . | Hyperacute GVHD, no. of patients (%) . | Other acute GVHD, no. of patients (%) . | P . |
|---|---|---|---|
| Total | 73 | 192 | — |
| Maximum grade | .5* | ||
| II | 44 (60) | 108 (56) | |
| III | 11 (15) | 54 (28) | |
| IV | 18 (25) | 30 (16) | |
| Organ distribution | |||
| Skin stage | .001 | ||
| 0 | 9 (12) | 66 (34) | |
| 1-2 | 12 (16) | 29 (15) | |
| 3-4 | 52 (71) | 97 (50) | |
| GI stage | .8 | ||
| 0 | 37 (51) | 91 (47) | |
| 1-2 | 19 (26) | 50 (26) | |
| 3-4 | 17 (23) | 51 (27) | |
| Liver stage | .9 | ||
| 0 | 57 (78) | 155 (81) | |
| 1-2 | 6 (8) | 17 (9) | |
| 3-4 | 9 (12) | 20 (10) | |
| Unknown | 1 (1) | 0 (0) | .9 |
| . | Hyperacute GVHD, no. of patients (%) . | Other acute GVHD, no. of patients (%) . | P . |
|---|---|---|---|
| Total | 73 | 192 | — |
| Maximum grade | .5* | ||
| II | 44 (60) | 108 (56) | |
| III | 11 (15) | 54 (28) | |
| IV | 18 (25) | 30 (16) | |
| Organ distribution | |||
| Skin stage | .001 | ||
| 0 | 9 (12) | 66 (34) | |
| 1-2 | 12 (16) | 29 (15) | |
| 3-4 | 52 (71) | 97 (50) | |
| GI stage | .8 | ||
| 0 | 37 (51) | 91 (47) | |
| 1-2 | 19 (26) | 50 (26) | |
| 3-4 | 17 (23) | 51 (27) | |
| Liver stage | .9 | ||
| 0 | 57 (78) | 155 (81) | |
| 1-2 | 6 (8) | 17 (9) | |
| 3-4 | 9 (12) | 20 (10) | |
| Unknown | 1 (1) | 0 (0) | .9 |
— indicates not applicable.
Comparing proportions of grade III-IV acute GVHD.